Need for services for the care and prevention of congenital disorders in South Africa as the country's epidemiological transition evolves
The lack of prioritisation of congenital disorders (CDs) in health care, and the limited resources allocated to prevention and to the care of those affected, is an issue of global concern. This is especially true in low-and middle-income countries (LMICs), where over 90% of CDs currently occur, resulting in 95% of CD deaths worldwide. [1, 2] In 2010 the World Health Organization's World Health Assembly (WHA) prioritised services for the care and prevention of CDs, particularly in LMICs, by passing Resolution WHA63. 17 . [2] This recognised the importance of CDs as a cause of stillbirths and neonatal deaths, their contribution to under-5 mortality, and their contribution to failure to attain Millennium Development Goal 4 (MDG4). WHA63.17 urged member states to recognise and address CDs as a public health issue. It also highlighted the lack of accurate epidemiological data available for many LMICs. [2] CDs are often undiagnosed or misdiagnosed and the cause of death wrongly attributed. Collectively, this prevents policy decision-makers from correctly assessing the burden of CDs in these LMICs. [3] In South Africa (SA), the constitutional, legal and regulatory framework exists to promote the development of services for the care and prevention of CDs. It is the government's responsibility to provide such services. To understand the renewed need for these services, it is important to consider, contemplate and review the epidemiological transition that has occurred in SA over the last 25 years.
Epidemiology of CDs in SA
Modelled data of genetic causes of CDs [1] and an estimate of teratogenic causes (A L Christianson, personal communication, 2014) indicate that a minimum of 6.8% of births, representing one in every 15 live births in SA, is affected by a CD. Of these, 80.5% are genetic or partially genetic in cause, while 19.5% are caused by teratogens. The latter is higher than the 10 -15% expected, owing to the high prevalence of fetal alcohol syndrome. [1] With 26.2% of CDs diagnosable in the first day of life, over 18 000 cases annually should be identified and reported in SA. [4] However, in 2012 only 2 174 CDs were reported via the Birth Defects Collection Tool administered by the National Department of Health (NDoH) (V Mtyongwe, personal communication, 2013). This indicates under-reporting of 88%! Although serious CDs can be life threatening or result in longterm disability, up to 70% can be prevented, cured or ameliorated by appropriate care. [1, 5] Many interventions are relatively inexpensive and low-tech, including surgery for congenital malformations and community-based preventive measures (e.g. iodine and folic acid fortification of staple foods). [1] 
Epidemiological transition
Epidemiological transition is the term for the change in population health statistics and pattern of diseases of a country or region, consequent on change in socioeconomic, education, infrastructure and healthcare development.
[1] Omran's three-stage model of epidemiological transition [6] has been used extensively to describe this process, particularly in industrialised nations. During this transition, infant and child mortality rates decrease and longevity rises, communicable diseases are controlled and eradicated, and noncommunicable and degenerative diseases emerge.
Most high-income or industrialised countries completed the first two stages of epidemiological transition decades ago. Stage one, the 'age of pestilence and famine' , is characterised by high fluctuating mortality rates, a low life expectancy at birth, and epidemics, famine and war as the main causes of death. This is followed by stage two, the 'age of receding pandemics' , when mortal ity starts to decrease and is accompanied by a marked increase in life expectancy, although high levels of communicable disease re main. [6] By controlling infectious diseases, reducing malnutrition and improving healthcare (including maternal) services, industrialised countries moved into stage three, the 'age of degenerative and man-made diseases' . [1, 6] Deaths from CDs remain invisible during this process of transition -'buried' among deaths caused by communicable diseases -to emerge only as the latter are adequately controlled. CDs then become proportionately more significant in overall neonatal, infant and child mortality.
CDs attained public health significance in industrialised nations as they moved into the third stage of epidemiological transition in the early 1960s. [1] Since 85 -90% of CDs have a genetic cause, their birth prevalence and resulting mortality remained high, [1] causing them to emerge and persist as a leading cause of child death in industria lised nations. A comparative study of death rates in England and Wales for 1901 and 1971 demonstrates this: a 68% reduction in non-communicable diseases occurred between 1901 and 1971, but the number of deaths caused by CDs remained un changed. [1] Epidemiological transition and CDs in SA SA, like many LMICs, has not followed the classic model of epidemiological transition experienced by industrialised nations, as a result of the HIV/AIDS and TB epidemics. [7] Fig. 1 plots the under-5 mortality rate (U5MR), infant mortality rate (IMR) and life expectancy at birth (longevity) data for SA over the past 25 years. From 1960, a clear trend of decreasing infant and under-5 mortality and increasing longevity continued until 1992, when life expectancy at birth peaked at 62.33 years. In 1993, both the U5MR and the IMR were at an all-time low of 58.2/1 000 live births and 45.1/1 000 live births, respectively. At this point it appeared as if SA would follow the three classic stages of epidemiological transition, approaching the early phases of transition from stage two of the 'age of receding pandemics' to stage three, the 'age of degenerative and man-made diseases' . [6] As a result of this falling childhood mortality in the early 1990s, CDs began to emerge as a public health issue. The Policy Guidelines for the Management and Prevention of Genetic Disorders, Birth Defects and Disabilities were published by the NDoH in 2001. [8] These outlined goals, objectives, strategies and delivery of clinical and laboratory services appropriate for the care and prevention of CDs. In 2004, the National Guidelines for the Care and Prevention of the Most Common Genetic Disorders, Birth Defects and Disabilities [9] [18] longevity [19] and the HIV epidemic. [20] were published, targeting primary healthcare providers, describing common CDs and strategies for their care and prevention. However, progress in epidemiological transition was dramatically interrupted and reversed in the mid-1990s with the advent of the concomitant HIV/AIDS and TB epidemics (Fig. 1) [7, 10, 11] Combined with the simultaneously increasing burden of non-communicable diseases in the population, this has led to a 'double burden of disease' . [11] In 2004, the prevalence of HIV infection among pregnant women plateaued at 30% and the U5MR started to reduce as a result of scaledup prevention of mother-to-child transmission and expanded rollout of antiretroviral (ARV) therapy. [12] The 2002 IMR of 53.2/1 000 live births dropped to 33.5 in 2012 (Fig. 1) . This is lower than the all-time best IMR of 45/1 000 live births in 1993 prior to the HIV/ AIDS epidemic. However, since 2011 both the IMR and U5MR have stagnated without significant further reductions. [13] A major effect of the HIV/AIDS and TB epidemics was to 'bury' the issue of CDs. As services for HIV/AIDS developed, funding and attention were diverted away from tertiary medical genetic services. If child mortality, including neonatal deaths, is to decrease further, control of these ongoing epidemics cannot be at the expense of other child healthcare needs. [12] Services for the care and prevention of CDs in SA are now at a lower base than in 2001. The 2003 recommendations for human capacity requirements to be trained and in-post by 2010 to meet the expected, and now increased, health needs remain unfulfilled. [14] Personnel levels are similar to, or lower than, those in 2001, with 11 medical geneticists today compared with four in 2001 and the 20 recommended by 2010. [14] Of the nine genetic counsellors in posts today, only four are in the state system (T Wessels, personal communication, 2014), compared with approximately 20 in 2001, and the 80 recommended. [14] Budget cuts have compromised medical genetic diagnostic laboratory services countrywide.
In 2013, SA was reported as the only country of eight emerg ing economies evaluated where positive development in improv ing medical genetic service structures had ceased and indeed regressed. [3] This decline will take time to reverse, and the dire state of these services, including the lack of policy addressing childhood disability, must be recognised by those in authority and urgently rectified.
Conclusion
While SA has missed attaining MDG4, it has significantly reduced the U5MR and IMR under difficult circumstances. The previous negative epidemiological transition, premised on the HIV/AIDS epidemic, has reversed and is once again positive with an IMR of 33/1 000 live births. [7] SA must now confront the issue of developing services for the care and prevention of CDs to reduce the stagnating child mortality rates. [13] The current IMR is now below 40/1 000 live births, at which point countries recognise the coming health needs of CDs and strive to implement appropriate services. [15] The proportion of deaths from CDs in SA under-5s was 4% in 2008, [3] and may be expected to rise as childhood deaths from CDs increasingly emerge as a leading cause of death in children while deaths from infections, particularly HIV/AIDS, decrease.
Legislation entitles those affected and living with CDs, including those disabled as a result, to the 'best possible patient care' in the prevailing circumstances, and provides for access to prevention by appropriate interventions. [16] With the global focus, including that of SA, shifting to non-communicable diseases, CDs must be con textualised as the first non-communicable disease experienced by people. CDs deserve to be prioritised, in accordance with WHA Resolution WHA63.17, to ensure the human dignity and con stitutionally and legally enshrined human rights of those affected and their families. [2, 17] 
